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Abstract Terminal oligopyrimidine (TOP) mRNAs are a group 
of messengers translationally regulated according to the growth 
status of the cell. Two hypotheses have been proposed for the 
mechanism of the regulation: (i) there is a specific translational 
regulator which can reversibly alter TOP-mRNA structure, (ii) a 
component of the general translational apparatus can specifically 
affect the translation of TOP-mRNAs. To verify one of the two 
hypotheses we induced a partial inhibition of translation 
initiation in Xenopus cultured cells and analyzed the effect on 
TOP-mRNA translation. Our results suggest that a specific 
regulator is necessary to explain the translational control of 
these of mRNAs. 
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1. Introduction 
The presence of a terminal oligopyrimidine tract (TOP) at 
the 5' end is the common structural feature of a group of 
mRNAs in vertebrates. The pyrimidine tract starts with a 
cytosine residue (cap site) and extends for 5-14 nucleotides. 
TOP-mRNAs include all ribosomal protein (rp) mRNAs plus 
few other messengers coding for products related to the pro-
tein synthesis apparatus, like for instance elongation factor 
(eEF)loc and eEF2. Their expression is specifically and coor-
dinately regulated at the translational level according, in gen-
eral, to the growth status of the cell. Translational control of 
TOP-mRNAs and in particular of rp-mRNAs has been 
studied in detail for more than ten years in many experimental 
systems. Translational activity is usually monitored by analyz-
ing the distribution of mRNAs between active polysomes and 
inactive subpolysomal mRNPs. It has been found that in ac-
tively growing cells TOP-mRNAs are mostly localized on pol-
ysomes whereas in quiescent or growth-inhibited cells they are 
on mRNPs (for review see [1,2]). The principal characteristics 
of TOP-mRNA translational control can be summarized as 
follows: (i) the regulation is specific (i.e. it does not involve 
other non-TOP-mRNAs), (ii) TOP-mRNAs move between 
polysomes and mRNPs without any irreversible modification, 
(iii) localization change does not require ongoing transcrip-
tion, (iv) the distribution of TOP-mRNA between polysomes 
and mRNPs is bimodal, that is the mRNAs are either fully 
loaded on polysomes or are on mRNPs. Sequence elements 
essential for translational control have been identified in the 5' 
UTR [3-5]. In particular, Meyuhas and collaborators showed 
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that a single mutation of a cytosine into alanine in the TOP 
region as well as change of position of the pyrimidines are 
sufficient to abolish translational control [6]. Although puta-
tive translational regulators which bind the 5' UTR of TOP-
mRNAs have been identified in two laboratories [7,8], clear 
evidence that any of them is involved in translational control 
has not yet been obtained. 
The lack of a good candidate as translational regulator 
keeps still open the issue of whether such an activity exists. 
In fact it has been proposed more than twenty years ago by 
H. Lodish that selective translational control can be obtained 
on the basis of differential affinity of mRNA for a limiting 
component of the translational apparatus [9]. The decrease of 
the amount (or activity) of the limiting factor would cause 
selective exclusion from polysomes of low affinity mRNAs. 
The model is attractive for its simplicity and its application 
to TOP-mRNA translational regulation has been recently hy-
pothesized [10]. Prime candidate as regulatory component is 
initiation factor (eIF)4E, whose activity is dependent on phos-
phorylation and interaction with regulatory proteins [11]. 
Although there is a correlation between eIF4E activity and 
TOP-mRNA translation, some data argue against its role in 
the regulation [1]. Also rpS6 phosphorylation has been shown 
to correlate with TOP-mRNA translational activation [12] 
and p70 S6 kinase has been proven to be necessary for the 
regulation [13]. Again, however, formal demonstration that 
any of the components of the general translation apparatus 
plays an active role in TOP-mRNA translational regulation is 
lacking. Therefore the only evidence for a regulation based on 
a general component is the so far unsuccessful search for a 
translational regulator, whereas the arguments for a specific 
mechanism can be defined as follows: (i) in vitro translation 
experiments failed to show that TOP-mRNAs have low affin-
ity for the translational apparatus [1], (ii) the distribution of 
TOP-mRNA between polysomes and mRNPs is bimodal 
whereas in the case of an affinity-based regulation it would 
be expected a statistical decrease in the size of polysomes 
during translational repression. However this last argument, 
which we believe is the most convincing, still does not exclude 
the possibility that the undetection of intermediate size poly-
somes is due to the low sensitivity of experimental analysis. 
Using Xenopus cultured cells as experimental system, we 
decided to verify if TOP-mRNA translational control can be 
the effect of decreased activity of a component of translational 
apparatus (Lodish model) or if it requires a specific transla-
tion effector. For this purpose we followed in parallel the 
kinetics of TOP-mRNA localization change during serum 
deprivation (control) and during sperimentally induced 'Lod-
ish conditions'. To decrease the efficiency of translation ini-
tiation, which is considered the limiting step of protein syn-
thesis, we used two different conditions: administration of 
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pactamycin and heat shock. Pactamycin is a antibiotic that 
inhibits translation initiation in eukaryotes by interfering with 
the attachment of initiator tRNA to the initiation complex 
[14]. Heat shock, on the other hand, induces complex response 
which includes a general translation repression. Data from 
various eukaryotic cells (reviewed in [15]) indicate that raising 
the temperature of a cell 5-10°C above their normal temper-
ature causes inhibition at the level of translation initiation, as 
evidenced by disaggregation of polysomes. The molecular 
mechanism responsible for the repression involves the two 
initiation factors indicated as key regulators of translation, 
eIF2 and eIF4E. Both factors are converted into the inactive 
form during heat shock, by phosphorylation of eIF2oc and 
dephosphorylation of eIF4E causing translation inhibition 
[15]. Therefore both pactamycin treatment and heat shock 
cause inhibition of initiation that, according to the affinity 
model, should induce selective exclusion of TOP-mRNAs 
from polysomes. Our analysis shows that initiation inhibition 
is not sufficient to induce a selective TOP-mRNA translation-
al repression and therefore a specific translational regulator is 
required to explain the mechanism of regulation. 
2. Materials and methods 
2.1. Cell culture 
Xenopus laevis kidney cell line В 3.2 was grown in medium contain-
ing 61% Leibovitz L-15, 10% fetal bovine serum (FCS), 29% H20, 
supplemented with 2 mM glutamine, 50 u/ml penicillin and 50 mg/ml 
streptomycin. Cells were cultured at 24°C. Serum deprivation was 
done as described [16], by transferring cells into serum-free medium. 
Heat shock temperature (33°C) was as described for Xenopus cell line 
A6 [17]. 
2.2. Polysome isolation 
1-2 X 106 cells, washed once with buffer A (100 mM NaCl, 2.7 mM 
KC1, 8 mM Na2HP04, 1.4 mM KH2P04), were treated directly on 
the plate with 300 μΐ of lysis buffer containing 10 mM NaCl, 10 mM 
MgCl2, 10 mM Tris-HCl pH 7.5, 1% Triton-XlOO, 1% NaDeoxycho-
late, 0.2 u/ml RNase inhibitor (Boehringer), 1 mM Dithiothreitol and 
transferred to an eppendorf tube. After a few minutes of incubation 
on ice with occasional vortexing, the extracts were centrifuged for 10 
min at 13 000 rpm in the cold room. The supernatant was frozen in 
liquid nitrogen and stored at — 70°C or loaded directly on a 15-50% 
linear sucrose gradient containing 30 mM Tris-HCl pH 7.5, 100 mM 
NaCl, 10 mM MgCl2, and centrifuged in an SW41 rotor for 110 min 
at 37 000 rpm. Fractions were collected monitoring the absorbance at 
260 nm and treated directly with proteinase K. 
2.3. Extraction and analysis of RNA 
Total RNA was extracted from gradient fractions by proteinase К 
method [18]. For Northern analysis, RNA was fractionated on form-
aldehyde-agarose gels and transferred on Gene Screen Plus membrane 
(NEN). Northern and dot blots were done essentially according to the 
manual. Xenopus rpL18 [19] and calmodulin [20] probes were pre-
pared by the random primer technique. Quantitation of Northern 
and dot blot analyses was done by Phosphorlmager analysis (Molec-
ular Dynamics) or by autoradiography and laser densitometer analy-
sis (LKB Ultroscan XL). 
3. Results and discussion 
3.1. TOP-mRNA specific translational control 
We have previously described that В 3.2 cells transferred 
into serum-free medium respond by rapidly altering the per-
centage of TOP-mRNAs loaded on polysomes which, within 
an hour, changes from 70-80 to 20-30 [16]. Here we used this 
experimental system as an example of TOP-mRNA transla-
tional control showed in many other eukaryotic cells (see 
Section 1) to analyze the mechanism of the regulation. The 
protocol we employ to evidence translational control is the 
following: (1) cytoplasmic extracts from cells grown in vari-
ous conditions are separated on sucrose gradient; (2) the gra-
dient is collected in 18 fractions while a general polysome 
profile is obtained by monitoring the absorbance of the gra-
dient at 260 nm; (3) RNA is extracted from the fractions, 
analyzed by Northern hybridization with different probes, 
and the quantitation of the hybridizations (as percentage of 
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Fig. 1. mRNA localization in В 3.2 cells during serum deprivation, pactamycm treatment, and heat shock. Cytoplasmic extracts were separated 
on sucrose gradients and collected while monitoring absorbance at 260 nm. RNA extracted from each fraction was analyzed on Northern blot 
with rpL18 and calmodulm probes. Quantitation of the signals is reported as percentage of mRNA in each fraction with the first fraction at 
the bottom of the gradient. The grey areas in the background represent a proportional reproduction of the absorbance profile of the gradients. 
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RNA in the fractions) is superimposed to the polysome pro-
file. This procedure gives essentially two kinds of information : 
the localization of the probed mRNA within the polysome 
profile, and the status of the polysomes in the cell. Cells 
were subjected to three different treatments: (i) serum depri-
vation, (ii) administration of 0.01 μg/ml of pactamycin, (iii) 
heat shock at 33°C. According to preliminary dose-response 
experiments, 0.01 μg/ml of pactamycin cause about 60% in-
hibition of amino acid incorporation (data not shown). After 
drug or heat shock treatments cells were analyzed according 
to the above described protocol and Northern blots were 
probed with at least one TOP-mRNA and at least one non-
TOP-mRNA. TOP-mRNA probes were Xenopus rpL18, rpL4, 
rpS25, whereas control non-TOP were Xenopus calmodulin, 
histone H3 and ß-actin. As already known, all TOP-mRNAs 
showed the same hybridization pattern and also the various 
control mRNAs gave similar results. Therefore only hybrid-
izations with rpL18 and calmodulin probes are reported Fig. 1 
as an example. Serum deprivation experiment (Fig. 1A) con-
firmed previously described [16] results: (i) within 1 h most of 
rpL18-mRNA moves from polysomes to subpolysomal 
mRNPs, (ii) the relocation does not involve passage of 
rpL18-mRNA on smaller size polysomes, (iii) calmodulin 
mRNA does not show any change of localization, (iv) in 
the general polysome profile 80S monomer increases gradually 
and polysome amount decreases maintaining approximately 
the same size. 
Pactamycin treatment (Fig. IB) produces a clearly different 
result. In fact rpL18-mRNA moves gradually from polysomes 
to mRNPs through an evident decrease of polysome size. A 
similar pattern is followed by calmodulin mRNA that how-
ever is never accumulated in the mRNP fractions. The general 
polysome profile, at variance with serum deprivation, shows a 
gradual size decrease of polysomes which after 1 h are mostly 
dimers and 80S monomers. 
The results obtained with the heat shock (Fig. 1С) are es-
sentially similar. The treatment induces a gradual decrease in 
polysome size both of rpL18 and calmodulin mRNAs. In this 
case the amount of rpL18-mRNA relocalized from polysomes 
to mRNPs is smaller compared to pactamycin treatment. This 
could be due to a different kinetics or to a different degree of 
translational inhibition. Also the effect of heat shock on the 
general polysomal profile is less drastic compared to pactamy-
cin treatment but the accumulation of 'halfmers' (i.e. poly-
somes with extra small subunits on mRNA) is more evident. 
As mentioned in Section 1, two hypotheses have been pro-
posed for the mechanism that regulates the translation of 
TOP-mRNAs. One postulates the existence of a translational 
regulator able to reversibly modify the structure of TOP-
mRNAs [1,7]. According to the circumstances the regulator, 
positive or negative, can render the mRNA either translatable 
or untranslatable. The other hypothesis states that TOP-
mRNAs have low affinity for a limiting component of the 
translational apparatus. Lowering the activity of such compo-
nent would be sufficient to cause a selective translational re-
pression of TOP-mRNAs [9]. The essential difference between 
the two hypotheses is that in the first model the decision 
'translate or not translate' is made at the level of mRNA, 
whereas in the second one it depends on the ribosome (or 
its accessory factors). As a consequence, during translational 
repression we can expect the following alternatives : (i) a cer-
tain amount of TOP-mRNAs became untranslatable (and lo-
calized on mRNPs) but the rest of the messengers is normally 
translated (fully loaded on polysomes); (ii) a certain amount 
of ribosomes became incompetent to translate TOP-mRNAs 
and we observe a gradual decrease of the number of ribo-
somes per messenger, that is a reduction of polysome size. 
To verify one of the hypotheses we asked a simple question : 
if we induce a decrease of translation initiation, is the result a 
selective translational repression of TOP-mRNA, similar to 
what is observed during serum deprivation? Both pactamycin 
treatment and heat shock gave a negative answer. In fact even 
at early time points the TOP-mRNA translational repression 
is not selective. Moreover the repression follows a different 
pattern compared to the translational control by serum dep-
rivation : there is a clear decrease of polysome size instead of 
the bimodal distribution. These results suggest that to obtain 
the TOP-mRNA translational control observed during serum 
deprivation is necessary that a specific regulator modifies 
translation availability of TOP-mRNAs, possibly by binding 
the 5' UTR. However a specific factor does not rule out the 
participation of some component of the general translation 
apparatus to the regulatory mechanism. For instance the 
well established involvement of p70 S6 kinase in TOP-
mRNA translational control suggests a role of phosphoryl-
ated rpS6 in the regulation. The function of rpS6 could be 
to interact positively or negatively with TOP-mRNAs and/or 
the specific regulator and make the regulation dependent on 
different signals. However any complex regulatory mechanism 
to be consistent with our results as well as with the other 
published data, must involve some reversible structural mod-
ification of TOP-mRNAs. 
3.2. General translational control 
The data presented in Fig. 1 evidence also the change of 
general polysome profile in the different treatments. It is gen-
erally assumed that the rate-limiting step of protein synthesis 
under physiological conditions is the initiation phase. For this 
reason the average polysomal density of one ribosome per 80-
100 nucleotides is not the maximum possible reached for in-
stance at pausing sites [21]. Any decrease of initiation activity 
would cause a consequent reduction of polysome size. In fact 
this is what we observe during pactamycin treatment and, to a 
minor extent, during heat shock. This is also what has been 
observed by other groups during heat shock [15], mitosis [22] 
and some cases of serum deprivation [23]. However the de-
crease of polysome size is not observed in our example of 
serum deprivation as well as in dexamethasone treated mouse 
lymphosarcoma cells [24] or differentiating mouse myoblasts 
[25]. In these latter examples, together with TOP-mRNA 
translational repression, there is a more or less pronounced 
decrease of protein synthesis activity and the amount of poly-
somes decreases. Polysome size, however, does not change 
indicating that initiation activity remains constant relatively 
to mRNA amount or that there is a parallel decrease of ini-
tiation and elongation. A possible explanation is that a pro-
tein synthesis decrease without changes in polysome size is a 
kind of 'first level' response of cell to extracellular signals 
(growth factor decrease, differentiation signals, etc.). At this 
stage there is a parallel decrease of initiation activity as well as 
of mRNA available for translation because of degradation or 
modification as in TOP-mRNAs. When the perturbation of 
the equilibrium is more severe, like for instance during heat 
shock or pactamycin treatment, initiation inhibition became 
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visible at the level of poly some size. In this scenario the spe-
cific T O P - m R N A translational regulation is an early cellular 
response and could be considered a very sensitive indicator of 
the growth conditions of the cell. Although speculative, we 
believe that this model could be useful in the analysis of the 
complexity of translation regulation. 
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